# Everest Medicines Announces Participation in Upcoming Investor Conferences

- Link: https://www.thailand-business-news.com/pr-news/everest-medicines-announces-participation-in-upcoming-investor-conferences
- Published: 2026-07-27T22:17:00+07:00
- Author: PR Newswire

SHANGHAI, July 27, 2026 /PRNewswire/ — Everest Medicines (HKEX 1952.HK, "Everest",
or the "Company"), a biopharmaceutical company focused on the discovery, clinical
development, manufacturing, and commercialization of innovative therapeutics, today
announced that Ian Woo, President and Chief Financial Officer, will participate 
in the upcoming investor conferences.

**Morgan Stanley Biotech Without Borders SeriesDate: Tuesday, July 28, 2026
Time:
US: 10:00am – 10:30am ET / 10:00pm – 10:30pm HKTFormat: Fireside chatWebcast: [https://morganstanley.webcasts.com/starthere.jsp?ei=1771095&tp_key=ca5039df5f](https://morganstanley.webcasts.com/starthere.jsp?ei=1771095&tp_key=ca5039df5f)

**2nd Annual Evercore China Biotech SummitDate: Tuesday, August 18, 2026
Time: 11:
00am HKTFormat: Presentation and Q&ALocation: The Ritz-Carlton Shanghai, Pudong

**About Everest Medicines**

Everest Medicines is a biopharmaceutical company focused on discovering, developing,
manufacturing and commercializing innovative pharmaceutical products that address
critical unmet medical needs for patients in global markets. The management team
of Everest Medicines has deep expertise and an extensive track record both in China
and with leading global pharmaceutical companies. The Company’s therapeutic areas
of focus include autoimmune, ophthalmology, critical care, and CKM (cardiovascular,
kidney, and metabolic) diseases. Everest Medicines has developed a fully integrated
commercialization platform that combines omnichannel commercial capabilities with
end-to-end product lifecycle management. Leveraging its proprietary mRNA platform,
the Company is advancing its existing pipeline, including mRNA in vivo CAR-T and
mRNA cancer vaccines, while selectively expanding into additional high-value therapeutic
areas with blockbuster potential, and accelerating its global expansion. For more
information, please visit the Company’s website: [www.everestmedicines.com](http://www.everestmedicines.com).

**Forward-Looking Statements**
This news release may make statements that constitute
forward-looking statements, including descriptions regarding the intent, belief 
or current expectations of the Company or its officers with respect to the business
operations and financial condition of the Company, which can be identified by terminology
such as "will," "expects", "anticipates", "future", "intends", "plans", "believes","
estimates", "confident" and similar statements. Such forward-looking statements 
are not guarantees of future performance and involve risks and uncertainties, or
other factors, some of which are beyond the control of the Company and are unforeseeable.
Therefore, the actual results may differ from those in the forward-looking statements
as a result of various factors and assumptions, such as future changes and developments
in our business, competitive environment, political, economic, legal and social 
conditions. The Company or any of its affiliates, directors, officers, advisors 
or representatives has no obligation and does not undertake to revise forward-looking
statements to reflect new information, future events or circumstances after the 
date of this news release, except as required by law.

---

  |  This article was produced by Cision PR Newswire, our trusted news partner. The views expressed and the content presented here are solely those of the author and may not fully reflect the opinions of Thailand Business News. |

---

 
**Read the original article :** [Everest Medicines Announces Participation in Upcoming Investor Conferences ](http://www.prnasia.com/story/archive/5012496_AE12496_0?rand=184833)